Professor Tracey Sach

Research groups

Research interests

• Health economics
• Economic evaluation methodology and application, particularly alongside randomised controlled trials
• Outcome measurement including non-monetary preference-based methods
• Special interest in the economics of dermatology, falls prevention, rehabilitation, public health and primary care
•  

Current research

I am an experienced collaborator, leading the health economic aspects within numerous NIHR funded clinical trials. Open to new collaborations.

Current on-going projects include:

Antibiotics for acute lower respiratory tract infection in older people. Lown M, Francis N, Little P, Griffiths G, Conroy S, Becque T, Sach T, Verheij T, Ogden M, Kumar R. NIHR HTA, £1,700,532.

Proactive against reactive therapy for the prevention of lichen sclerosus exacerbation and progression of disease – a pragmatic parallel group randomised controlled trial with embedded economic evaluation and process evaluation (PEARLS). Simpson R, Thomas K, Daniels J, McPherson T, Sivalingam V, Rees S, Hillman S, Sach T, Ogollah R, Sudhakaran S, Baumhauner C, Norman E. NIHR HTA, 57 months, £1,636,175.

Investigating the benefits and harms of reduced daily dose oral isotretinoin in the treatment of acne: A parallel group, assessor blind, non-inferiority, multicentre randomised controlled trial, with an internal pilot (AcneID). Burden-Teh E, Thomas K, Ravenscroft J, Williams H, Healy E, Layton A, Santer M, Northover G, Radley K, Mitchell E, Hepburn T, Leighton P, Sach T, Thompson A, Ramesh G, Leng S. NIHR HTA, 60 months, £2,148,574.06.

Cellulitis Optimal Antibiotic Treatment: COAT study. Francis N, Santer M, Thomas K, Levell N, Little P, Stuart B, Nuttall J, Read R, Sach T. NIHR HTA, 48 months, £1,476,575.

Developing and testing an online intervention to support self-management, improve outcomes and reduce antibiotic use in acne. Santer M, Muller I, Stuart B, Thomas K, Layton A, Little P, Yardley L, Francis N, Ridd M, Sach T. Langan S, Soulsby I, Patel M, Dove S, Griffiths G, Thompson A.  NIHR Programme Grants for Applied Research, £1,901,577.

Best systemic treatments for adults with atopic eczema over the long term (BEACON): A randomised, assessor-blind trial comparing ciclosporin, methotrexate and dupilumab. Smith C, Pink A, Chalmers J, Emsley R, Williams H, Parmar M, Sach T, Reynolds N, Smith S, Murphy C, Cape A, Kelly J, Burton T, Dougans A, Kelly J, Proctor A. NIHR HTA Programme, 48 months, £1,899,852

RETurn to work After stroKE (RETAKE). Radford K, Bowen A, Farrin A, McKevitt C, Sach T, Walker M, O’Connor R, Watkins C. (NIHR HTA, 01/01/2017 for 54 months). Trial website: https://www.nottingham.ac.uk/research/groups/longtermconditions/vocational-rehabilitation/retake/index.aspx

Research projects